top of page

Expanded Legal Disclaimer

Helix Cancer Strategies Inc. provides commercial execution, business strategy, financing readiness, management support, and project execution services. Helix is not registered with the U.S. Securities and Exchange Commission or FINRA as a broker-dealer, investment adviser, or placement agent.
Helix does not offer or sell securities, solicit investments, recommend securities to investors, negotiate securities transactions, handle investor funds or securities, or execute securities transactions on behalf of clients or investors. Helix does not provide investment, legal, tax, or securities advice.
Any capital-related engagement is limited to strategy, business and financial preparation, development of company materials, management support, project coordination, diligence preparation, and other issuer-side operational services. Decisions concerning an offering, investor communications, financing terms, and the issuance of securities remain the responsibility of the client and its officers, directors, legal counsel, and, where applicable, a properly registered broker-dealer or other regulated professional.
Helix is compensated for its professional services, time, deliverables, and execution capacity. Its compensation is not contingent upon the completion of a securities transaction and is not calculated as a percentage of, or by reference to, capital raised.

Scope of Engagement & Definitions

Helix Cancer Strategies Inc. provides strategic commercial consulting and capital readiness advisory specifically for the oncology sector. 'Services' encompass market segment identification, commercial narrative development, and tactical negotiation support. 'Capital Readiness' refers to the structured preparation of investor materials and data rooms; however, Helix does not act as a broker-dealer or investment advisor. All financial and strategic decisions remain the sole responsibility of the Client's officers and directors. Detailed definitions of specific commercial milestones and performance indicators are established within individual statement of work (SOW) documents, ensuring absolute alignment on expected outcomes and commercial maturity scores.

Regulatory Compliance

This section is reserved for long-form legal disclosure, regulatory notes, and liability disclaimers relevant to healthcare consulting operations. Future updates will detail specific jurisdictional compliance and professional standards maintained by Helix Cancer Strategies.

bottom of page